Multitarget tyrosine kinase inhibition: ''And the winner is ..."

被引：11
|
作者：
Verweij, Jaap [1 ]
de Jonge, Maja [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 17期
关键词：
D O I：
10.1200/JCO.2007.10.7318
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2340 / 2342
页数：3
相关论文
共 50 条
  • [21] Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition
    Force, Thomas
    Krause, Daniela S.
    Van Etten, Richard A.
    NATURE REVIEWS CANCER, 2007, 7 (05) : 332 - 344
  • [22] TYROSINE PROTEIN-KINASE INHIBITION AND CANCER
    BOUTIN, JA
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1994, 26 (10-11): : 1203 - 1226
  • [23] Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors
    Liu, Yong
    Ramirez, Jacqueline
    Ratain, Mark J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (06) : 917 - 920
  • [24] Screening serine/threonine and tyrosine kinase inhibitors for histidine kinase inhibition
    Wilke, Kaelyn E.
    Fihn, Conrad A.
    Carlson, Erin E.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (19) : 5322 - 5326
  • [25] INHIBITION OF PROTEIN-KINASE-C BY THE TYROSINE KINASE INHIBITOR ERBSTATIN
    BISHOP, WR
    PETRIN, J
    WANG, L
    RAMESH, U
    DOLL, RJ
    BIOCHEMICAL PHARMACOLOGY, 1990, 40 (09) : 2129 - 2135
  • [26] BIOLOGICAL PREDICTIVE FACTORS IN ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH MULTITARGET TYROSINE KINASE INHIBITOR SORAFENIB
    Negri, F.
    Campanini, N.
    Dal Bello, B.
    Rossi, S.
    Tinelli, C.
    Bisagni, G.
    Porta, C.
    Salvagni, S.
    Ardizzoni, A.
    Silini, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 95 - 95
  • [27] Novel Pyrimidines as Multitarget Protein Tyrosine Kinase Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
    Sun, Bo
    Liu, Xiaowen
    Zheng, Xu
    Wang, Changyuan
    Meng, Qiang
    Sun, Huijun
    Shu, Xiaohong
    Liu, Kexin
    Sun, Xiuli
    Li, Yanxia
    Ma, Xiaodong
    CHEMMEDCHEM, 2020, 15 (02) : 182 - 187
  • [28] Nintedanib, a multitarget tyrosine kinase inhibitor, suppresses postoperative peritoneal adhesion formation in a rat model
    Fu, Yan
    Gong, Tao
    Tsauo, Jiaywei
    Sang, Mingchen
    Zhao, He
    Zhang, Xiaowu
    Li, Jingui
    Li, Xiao
    SURGERY, 2021, 170 (03) : 806 - 812
  • [29] CML and tyrosine kinase inhibition: the hope becomes reality
    Apperley, Jane F.
    LANCET HAEMATOLOGY, 2015, 2 (05): : E176 - E177
  • [30] Kaposi's Sarcoma Under Tyrosine Kinase Inhibition
    Schmidt, Kathie
    Kriesen, Ursula
    Panzer, Ruediger
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 119 (12): : 217 - 217
12345